Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam

NCT03398083 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute on Drug Abuse (NIDA)